Clinical Trials Logo

Filter by:
NCT ID: NCT04808297 Completed - Clinical trials for Neuronal Ceroid-Lipofuscinoses

Trehalose in Subjects With Neuronal Ceroid Lipofuscinoses

3AL-CLN36
Start date: August 1, 2020
Phase:
Study type: Observational

Neuronal Ceroid Lipofuscinoses (NCL) or Batten's disease are the most common juvenile neurodegenerative disease, characterized by early blindness, movement disorders, cognitive and behavioral impairment, epilepsy, and retinopathy. This study aims to collect clinical and laboratory data of patients with NCL taking Trehalose.

NCT ID: NCT04808180 Completed - Clinical trials for Molar Incisor Hypomineralization

Clinical Efficacy of Biomimetic Hydroxyapatite in the Treatment of Molar Incisor Hypomineralization.

Start date: March 25, 2021
Phase: N/A
Study type: Interventional

The aim of the following study is to evaluate che clinical efficacy of a toothpaste with biomimetic hydroxyapatite for the management of Molar-Incisor Hypomineralization. Patients who agree to participate to the study will use Biorepair toothpaste for the first 7 days of the month for 3, 6 and 9 months. The following indices will be measured: BEWE, Bleeding Index, Gingival index, Plaque index and the dental sensitivity test. The contralateral tooth will be used as control if not affected by MIH; otherwise, adjacent teeth will be considered.

NCT ID: NCT04807595 Completed - Breast Cancer Clinical Trials

Estimation of the Prevalence of HER2 Low and Describe the SoC, Treatment Patterns, and Outcome in Real-world Practice Among Unresectable and/or Metastatic Breast Cancer Patients With HER2 Low Status

Start date: May 28, 2021
Phase:
Study type: Observational

This is a worldwide, multicenter, non-interventional, retrospective study of patient medical records from metastatic breast cancer (mBC) patients previously identified as human epidermal growth factor receptor 2 negative (HER2-neg), regardless of hormone status.

NCT ID: NCT04806594 Completed - Acne Clinical Trials

Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar.

Start date: September 25, 2020
Phase: N/A
Study type: Interventional

The scope of this open label clinical trial is to evaluate and confirm the performance of Papix acne scar in the prevention and improvement of acne scars in subject suffering for mild to moderate acne. The product will be applied for 8 consecutive weeks and 3 clinical follow up visits will be performed.

NCT ID: NCT04803578 Completed - Clinical trials for Arthroplasty, Replacement, Knee

The Effectiveness of Rehabilitation in Gait Recovery After Knee or Hip Arthroplasty

Fast-Track2
Start date: January 1, 2017
Phase:
Study type: Observational

This study aims to evaluate the effectiveness of rehabilitation on gait recovery in subjects after knee or hip arthroplasty. Assessment is performed the day after admission (T0) and the day of discharge (T1), in a post-acute rehabilitation hospital, through an optoelectronic system (BTS DX-400). Other functional scales are administered to the subjects. during the rehabilitation period, subjects received conventional physiotherapy.

NCT ID: NCT04803565 Completed - Parkinson Disease Clinical Trials

The Effect of Personalized Shoe Insole on the Gait of Parkinson's Disease Subjects

InsolePD
Start date: March 4, 2021
Phase: N/A
Study type: Interventional

This study aims to assess the efficacy of custom-made shoe insoles, for subjects with Parkinson's Disease (PD). To do that, a sample of PD subjects has been randomly assigned to an intervention group that will receive the custom-made insoles or a control group that will receive a sham insole without any specific manufacturing. Both groups will receive Physiotherapy and Occupational Therapy according to PD rehabilitation guidelines. The principal outcome will be the Time Up&Go test time, secondary outcomes 10 Meters Walking test speed, Berg Balance Scale score, SF12 score, and orthesis liking.

NCT ID: NCT04803344 Completed - Clinical trials for Health Care Utilization

The Effectiveness of Expressive Writing on a Sample of New Mothers

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

This pilot study aims to evaluate the effects of an expressive writing intervention on a sample of new mothers after the childbirth on the psychological health and on the healthcare costs. The mothers were evaluated also in a follow-up one month after the end of the expressive writing intervention.

NCT ID: NCT04802070 Completed - Sarcoma Clinical Trials

Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.

Start date: January 11, 2021
Phase: Phase 1
Study type: Interventional

Monocentric, phase I study for advanced sarcoma with adoptive immunotherapy with Cytokine-Induced Killer (CIK). In the first part of the study Patient's' peripheral blood will be collected and CIK cell expansion and storage will occur at the Regina Margherita Children's Hospital Cell Factory. In the second part of the study the Maximum Tolerated Dose (MTD) will be determined in order to find the Recommended Dose for Phase II (RP2D)

NCT ID: NCT04801992 Completed - Cataract Clinical Trials

Trial Following Subjects Bilaterally Implanted With Mini Well Ready For 2 Years After the Second Eye Implant

Start date: October 26, 2020
Phase:
Study type: Observational

The study objective is to evaluate the visual performance of MINI WELL Ready at 24 months following the second eye implant. The objectives of safety are to evaluate the rate of Secondary Surgical Interventions related to the optical properties of the IOL for first and second operative eye separately at 24 months and the rate of visual disturbances and distortions as reported by the subjects as detected by using the Halo & Glare Simulator.

NCT ID: NCT04801173 Completed - Obesity Clinical Trials

Ketogenic Diet in PCOS With Obesity and Insulin Resistance

VLCKD
Start date: March 2, 2021
Phase: N/A
Study type: Interventional

The purpose of the VLCKD randomized clinical trial is to demonstrate the superiority of very low calorie ketogenic diet with respect to the standard low calorie diet in reducing body weight and insulin resistance in obese and insulin resistant patients with Polycystic Ovary Syndrome